Multiple tyrosine kinase inhibitors before allogeneic stem cell transplantation for chronic myeloid leukemia: toxicity and efficacy in a single-center experience

Pol Arch Intern Med. 2020 Jun 25;130(6):553-556. doi: 10.20452/pamw.15351. Epub 2020 May 11.

Authors

Grzegorz Helbig¹, Katarzyna Duda², Helena Krzemień², Martyna Włodarczyk², Dariusz Kata², Agata Wieczorkiewicz-Kabut²

Affiliations

¹ Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland. [email protected]
² Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland

PMID: 32388967
DOI: 10.20452/pamw.15351

No abstract available

Publication types

Letter

MeSH terms

Chronic Disease
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
Protein Kinase Inhibitors / adverse effects

Substances

Protein Kinase Inhibitors